The interdisciplinary working group "Biliary Atresia" is dedicated to advancing both clinical and basic research in the field. Through collaborative efforts, we aim to make significant strides in understanding and addressing the challenges associated with biliary atresia. Join us in our mission to make a lasting impact on the lives of patients and their families.
About BARD
The Biliary Atresia Research Group is committed to advancing knowledge and understanding of biliary atresia through clinical and basic research efforts. Our goal is to improve the diagnosis, treatment, and outcomes for patients affected by biliary atresia. Join us in our journey to drive progress and make a difference in the lives of those impacted by this condition.
Paper of the month
Every year hundreds of papers, studies and reviews are published in this field. The sheer number and diversity of these publications makes it increasingly difficult to keep track. Therefore, we offer the community the opportunity to suggest new and interesting papers to be shared on this website. Please send your choice to bard-online@magenta.de and the relevant members of the Executive Board will add your paper of the month to the list, which will be constantly updated. Each new entry will be displayed with title, author list, abstract (or full paper if open source) and the name of the BARD member who suggested it.
Forum
Welcome to the restricted BARD-online forum. Here you have access to the history of the meetings since 1999 (programs, participants, photos, etc.). You can also stream the entire BARD meeting in Bruges.
Most importantly, the forum, which is restricted to BARD members, gives you the opportunity to communicate about anything important. Whether you have questions, suggestions, ideas or new information to share. This is the way to reach the whole community and help keep it together.
PARTNERS
BARD collaborates with leading medical institutions, research organizations, and advocacy groups to drive progress in the field of Biliary Atresia. Together, we work towards advancing knowledge, developing innovative therapies, and providing comprehensive support for patients and families affected by this condition.
